Showing results (321-330 of 3,079) with videos related to
Sort By:
Pageof 308
Drug Safety|August 31, 2025
R Value-Based Criteria Outperform Alkaline Phosphatase Less than Twice Normal in Identifying Hy's Law Cases in Clinical TrialsJasmine Amirzadegan, Edwige Chiogo Vouffo, Ling Lan, et al.Drug Safety|October 25, 2019
Complementing Observational Signals with Literature-Derived Distributed Representations for Post-Marketing Drug SurveillanceJustin Mower, Trevor Cohen, Devika SubramanianDrug Safety|June 25, 2015
Product-Specific Regulatory Pathways to Approve Generic Drugs: The Need for Follow-up Studies to Ensure Safety and EffectivenessAaron S Kesselheim, Joshua J GagneDrug Safety|June 28, 2015
Prevalence, Nature, Severity and Risk Factors for Prescribing Errors in Hospital Inpatients: Prospective Study in 20 UK HospitalsDarren M Ashcroft, Penny J Lewis, Mary P Tully, et al.Drug Safety|June 26, 2015
Accidents and Incidents Related to Intravenous Drug Administration: A Pre-Post Study Following Implementation of Smart Pumps in a Teaching HospitalAurélie Guérin, Julien Tourel, Emmanuelle Delage, et al.Drug Safety|May 27, 2015
Update on Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on QT Interval, Left Ventricular Dysfunction and Overall Risk/BenefitRashmi R Shah, Joel MorganrothDrug Safety|June 21, 2015
Indigenous Medicine Use for Sex Selection During Pregnancy and Risk of Congenital Malformations: A Population-Based Case-Control Study in Haryana, IndiaSutapa Bandyopadhyay Neogi, Preeti H Negandhi, Navraj Sandhu, et al.Drug Safety|February 18, 1998
A risk-benefit assessment of aprotinin in cardiac surgical proceduresW B Dobkowski, J M MurkinDrug Safety|May 30, 2020
Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk AssessmentMiranda Davies, Vicki Osborne, Samantha Lane, et al.Drug Safety|June 27, 2003
Use of herbal medicines by patients receiving warfarinRaymond S M Wong, Gregory Cheng, Thomas Y K ChanPageof 308